Compliance Program Effectiveness Assessment

Is your program meeting the latest OIG guidelines?

Get an objective review of where you stand relative to the seven elements of an effective compliance program

Our team of healthcare compliance experts will help you assess your program’s effectiveness and identify opportunities to improve

Feedback and recommendations from the industry leader

The ability to demonstrate the effectiveness of a compliance program is a key priority for healthcare organizations whether it is to the governing body, senior leadership or federal and state regulators. Having an independent, objective assessment of the compliance program’s effectiveness is a means of verifying the resources devoted to the compliance program are justified and appropriate when considering the risk profile of the organization. It also provides your organization with information regarding any gaps in the implementation and ongoing functions of the program.

Clearwater addresses this need through our Compliance Program Effectiveness Assessment (CPEA) which is designed to evaluate a client’s existing compliance program against the seven elements of an effective compliance program as outlined in the Federal Sentencing Guidelines and the Office of Inspector General’s (OIG) compliance program guidance documents, including updates published in late 2023. Our team provides feedback and, as appropriate, recommendations to improve the effectiveness of the implementation and ongoing operation of the compliance program.

Clearwater’s CPEA at a glance

Program Effectiveness

Assesses your compliance program for evidence to support the Federal Sentencing Guidelines and OIG’s seven elements of an effective compliance program by examining regulatory requirements, industry best practices, and enforcement trends.

Expertise

Clearwater’s extensive experience with healthcare operations enables us to provide proven best practice recommendations for compliance operations to our clients.

Evaluation

We interview key board members, executives, managers, and employees and review compliance program documentation. 

Reporting

The CPEA includes a report of observations and recommendations to address each of the seven elements of an effective compliance program. 

Featured Experts

Our HIPAA experts have years of experience working in healthcare organizations across the industry, bringing unique expertise to your organization.

SME Highlight

Andrew Mahler, JD, CIPP/US, CHC, CHPC, CHRC

Andrew Mahler is the Vice President of Privacy, Compliance Services at Clearwater and has supported diverse clients with privacy and […]

Read More

SME Highlight

Melissa Andrews, CP, CHPC, CHC

Melissa Andrews is a Principal Consultant specializing in privacy and compliance at Clearwater. Melissa brings Clearwater clients more than ten […]

Read More

Why Clearwater?

No one knows HIPAA compliance like Clearwater. Our HIPAA experts come from different disciplines and are some of the best in the field.

We understand the highly complex regulatory landscape and have the skills and expertise to navigate your team through it to ensure long-term compliance.

 

Want to Know More?

Contact Us

ClearAdvantage®

Looking for helping building and executing a program?

Recognized by healthcare organizations as the industry leader in Compliance and Risk Management solutions for eight consecutive years, Clearwater provides the expertise and capabilities you need in a complete managed services program.

Our ClearAdvantage managed services program transforms the burden of cybersecurity and compliance from a liability into a competitive advantage.

Featured Resources

Navigating the HIPAA Privacy Rule for Reproductive Healthcare: Compliance Essentials Before the December 2024 Deadline

Navigating the HIPAA Privacy Rule for Reproductive Healthcare: Compliance Essentials Before the December 2024 Deadline

In an era where the privacy of reproductive healthcare has become a topic for debate, healthcare organizations face growing fears and challenges over the potential misuse of sensitive patient data. Recent legal developments, coupled with the shifts following the Dobbs v. Jackson decision, have shown the urgent need for robust safeguards. Notably, the December 23, 2024 compliance deadline for the HIPAA Privacy Rule Final Rule to Support Reproductive Health Care Privacy offers a pivotal moment to address these concerns.

Connect
With Us